TRIM 25-40% INTO 387-391 ZONE; DO NOT PRESS SHORT; STOP AT 365; HOLD REMAINING POSITION OR AWAIT CONFIRMATION BELOW 365 TO ADD SHORT/PUT HEDGE

• Q2 came in at 6.04 versus Q1 at 6.90 (12.5% sequential decline) but Q4 2025 was ~0.01, Q3 2025 was 2.59, Q2 2025 was 3.74, showing clear year-over-year operational improvement trajectory; cherry-picking one quarter as thesis-breaker ignores the lumpy nature of insurer earnings and management's explicit glide path guidance
• 200 SMA sits at 353.34, climbed from low 320s in June; price is 6.4% above 200 SMA; MACD histogram crossed positive October 5 and has been building daily at 0.61, 0.92, 1.10; RSI bounced from 33 oversold to 45 mid-band; ATR contracted from 12 to 9 (coiled spring)
• Low volume on October 7 bounce (5.62 million shares) off support is constructive basing pattern, not weak conviction; high volume on July 16 was capitulation (sellers exhausting); aggressive analyst misapplies volume interpretation at inflection points
• 90% beat probability means market has already absorbed skepticism; with stock down 13% from August high and sitting on long-term support, clean beat with cautious guidance more likely triggers relief rally ('sell rumor, buy news') than 'beat and drop'
• UNH at 0.62 beta and 2.47% yield is defensive rotation play; rate headwinds (10-year yields at 2002 highs) differ from sector headwinds; money rotating out of consumer discretionary has to go somewhere
• Full short into long-term uptrend, six days before binary catalyst, with stock already off 13% and testing structural support is low-probability, high-tail-risk setup; clean print with stable MLR guidance could trigger 5-8% single-session rally and squeeze shorts

→ vs aggressive: Sequential EPS argument misframes recovery as requiring perfectly linear ramp; Q1 to Q2 decline happens from level 60%+ above prior year comp; four-quarter trajectory (0.01, 2.59, 3.74, 6.04) still shows clear improvement

→ vs aggressive: Technical analysis ignores 200 SMA at 353.34; focusing only on 50 SMA rolling over misses the structural floor where long-term trend support lives; move to 360-365 tests 200 SMA zone where shorts become underwater

→ vs aggressive: Volume interpretation is backwards; low volume on bounce off support is healthy basing, not weak conviction; capitulation was July 16 high-volume breakdown; high-volume breakdown has not occurred

→ vs aggressive: Polymaker/beat probability logic is flawed; 90% priced beat means expectations already absorbed, not that downside is asymmetric; stock at corrective low with low expectations more likely produces relief rally than 'beat and drop'

→ vs aggressive: Macro/rate headwind conflates sector headwinds with rate headwinds; defensive rotation into quality/low-beta/dividend names happens during growth slowdown regardless of Fed posture

→ vs aggressive: Pressing full directional short into binary catalyst at structural support is escalation that turns prudent risk management into blowup risk; original trader plan had defined risk, aggressive escalation does not

Execute the trader's plan with modifications: trim 25-40% on rally into 387-391 zone, add defined downside protection using 20-30% of trim proceeds (long-dated puts around 360 or collar using 365 puts plus 400 calls), set explicit pre-committed re-entry criteria, and reallocate underweight within healthcare rather than to cash

• Trim 25-40% on rally into the 387-391 zone (scale out rather than waiting for perfect 389.45 fill)
• Use 20-30% of trim proceeds to buy defined downside protection through the catalyst (long-dated puts around 360 or collar using 365 puts plus selling calls around 400)
• Set explicit pre-committed re-entry criteria: below 365 on elevated volume adds to underweight; holds 365 and reclaims 389 with MACD above zero redeploys trimmed capital; choppy 365-389 range stays underweight
• 50 SMA rolling over with confirmed lower-high sequence signals medium-term trend broken
• 200 SMA at 353 is a reference level, not a floor—UNH has experienced 10-15% drawdowns from 200 SMA tests historically
• Binary catalyst combined with hostile macro and broken medium-term trend calls for reduced exposure, not maximum aggression
• Underweight should be paired with reallocation within healthcare (less MA reimbursement exposure, less MLR volatility) rather than sitting in cash
• Beta of 0.62 means UNH holds up better than cyclicals but doesn't rally when rates are hostile at 2002 highs
• Low volume on successful support test can signal basing patterns, not just distribution
• A 90% priced beat in a stock that's corrected 13% and tests structural support can clear a low bar and trigger relief rally

→ vs aggressive: Pressing a full short six days before a binary catalyst in a Dow 30 component trading 6.4% above its 200-day moving average is a directional bet dressed in risk management language, not discipline

→ vs aggressive: Low volume on successful test of support can indicate basing patterns, not distribution—low volume should equally reassure that there is no stampede out the door

→ vs aggressive: A 90% Polymarket-implied beat in a stock that's already corrected 13% and is testing structural support can mean the bar is low enough to clear and trigger relief rally, not automatically asymmetric to the downside

→ vs conservative: The 200 SMA at 353 being 6.4% below current price does not mean the stock cannot trade down to or through it before finding support—UNH has had 10-15% drawdowns from 200 SMA tests over the past several years

→ vs conservative: Internal inconsistency: accepting trim logic, $365 stop level, and underweight recommendation but then recommending HOLD through the same binary catalyst creates an incompatible position

→ vs conservative: Defensive rotation does not automatically flow into managed care with 10-year yield at 2002 highs—conflating relative outperformance (beta 0.62) with absolute upside is not the same trade

→ vs conservative: The 'patient longs' thesis presenting 5% downside versus 23% upside requires multiple sequential things to go right including macro softening, defensive rotation, clean catalyst print, and 50 SMA reclamation—a low-probability path presented as a base case